Table 4.
Subgroup analysis for overall and recurrence-free survival
| Subgroup | Variable | Categories/units | n |
Overall survival |
Recurrence-free survival |
||
| HR (95% CI) | P-value | HR (95% CI) | P-value | ||||
| Surgical margins = positive | Treatment | Chemo alone | 21 | 1 | 1 | ||
| 5FU-RT/XRT | 0.47 (0.100–2.191) | 0.3 | 1.58 (0.206-12.154) | 0.7 | |||
| Stage T3/4 | Treatment | Chemo alone | 66 | 1 | 1 | ||
| 5FU-RT/XRT | 0.65 (0.294–1.454) | 0.3 | 0.78 (0.352-1.709) | 0.5 | |||
| Node positive | Treatment | Chemo alone | 94 | 1 | 1 | ||
| 5FU-RT/XRT | 0.92 (0.404–2.081) | 0.8 | 1.10 (0.489-2.482) | 0.8 | |||
5FU-RT: 5-fluorouracil + radiation; XRT: Capecitabine + radiation; HR: Hazard ratio.